Tech Focus: How is HTS accelerating early-stage drug discovery?
Drug Discovery World
AUGUST 29, 2024
For example, multiple RNA helicases are being targeted for cancer and viral infections before their catalytic properties are well understood. According to the company, the dual-recognition, DNA-coupled technology offers high specificity, reducing the risk of wrong targets. appeared first on Drug Discovery World (DDW).
Let's personalize your content